Christopher Mount, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 7 | 2024 | 1505 | 0.810 |
Why?
|
| Gangliosides | 2 | 2022 | 133 | 0.760 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2019 | 39 | 0.670 |
Why?
|
| Afferent Pathways | 1 | 2019 | 304 | 0.610 |
Why?
|
| Myelin Sheath | 2 | 2017 | 653 | 0.520 |
Why?
|
| Somatosensory Cortex | 1 | 2019 | 516 | 0.500 |
Why?
|
| Corpus Callosum | 2 | 2019 | 755 | 0.490 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2024 | 2568 | 0.490 |
Why?
|
| Motor Cortex | 2 | 2019 | 1015 | 0.460 |
Why?
|
| Lysine | 1 | 2018 | 989 | 0.430 |
Why?
|
| Glioma | 5 | 2022 | 3523 | 0.420 |
Why?
|
| Histones | 3 | 2022 | 2595 | 0.400 |
Why?
|
| Neuroglia | 2 | 2017 | 961 | 0.400 |
Why?
|
| Oligodendroglia | 3 | 2024 | 538 | 0.370 |
Why?
|
| Neurons | 4 | 2019 | 9504 | 0.360 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 1315 | 0.350 |
Why?
|
| Brain Neoplasms | 7 | 2024 | 9182 | 0.350 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2024 | 133 | 0.220 |
Why?
|
| Neurofibromin 1 | 1 | 2024 | 190 | 0.210 |
Why?
|
| Brain Stem Neoplasms | 1 | 2022 | 191 | 0.170 |
Why?
|
| Glioblastoma | 2 | 2024 | 3523 | 0.160 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 210 | 0.150 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2024 | 954 | 0.150 |
Why?
|
| T-Lymphocytes | 4 | 2024 | 10273 | 0.140 |
Why?
|
| Astrocytoma | 1 | 2022 | 780 | 0.140 |
Why?
|
| Teratoma | 1 | 2020 | 405 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 3619 | 0.130 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 1448 | 0.120 |
Why?
|
| Methylation | 1 | 2018 | 1077 | 0.120 |
Why?
|
| Oligodendroglioma | 1 | 2016 | 278 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 2039 | 0.120 |
Why?
|
| Learning | 1 | 2024 | 1762 | 0.120 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2015 | 264 | 0.110 |
Why?
|
| Neurotransmitter Agents | 1 | 2017 | 666 | 0.110 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 1044 | 0.100 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 3939 | 0.100 |
Why?
|
| Oncogenes | 1 | 2018 | 1235 | 0.100 |
Why?
|
| Cues | 1 | 2017 | 884 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 1357 | 0.100 |
Why?
|
| Brain | 2 | 2020 | 27438 | 0.090 |
Why?
|
| Single-Cell Analysis | 3 | 2018 | 2531 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 2003 | 0.090 |
Why?
|
| Neural Stem Cells | 2 | 2016 | 892 | 0.090 |
Why?
|
| Mice | 8 | 2024 | 82045 | 0.090 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2014 | 953 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2018 | 10494 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2023 | 5192 | 0.060 |
Why?
|
| Animals | 8 | 2024 | 169418 | 0.060 |
Why?
|
| Cell Differentiation | 3 | 2024 | 11674 | 0.060 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2024 | 170 | 0.050 |
Why?
|
| Mutation | 3 | 2024 | 30243 | 0.050 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2023 | 149 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4417 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2024 | 920 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2024 | 556 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2020 | 227 | 0.040 |
Why?
|
| Motor Activity | 2 | 2024 | 2722 | 0.040 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2022 | 263 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7895 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2024 | 1415 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2017 | 2575 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 369 | 0.030 |
Why?
|
| Macrophages | 2 | 2024 | 5797 | 0.030 |
Why?
|
| Antibodies | 1 | 2024 | 2425 | 0.030 |
Why?
|
| Humans | 13 | 2024 | 768451 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1839 | 0.030 |
Why?
|
| Neoplasms | 1 | 2024 | 22386 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 17149 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2020 | 2633 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 949 | 0.030 |
Why?
|
| Fetus | 1 | 2020 | 1883 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 9558 | 0.020 |
Why?
|
| Point Mutation | 1 | 2016 | 1596 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 2017 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 1755 | 0.020 |
Why?
|
| Proteomics | 1 | 2024 | 3901 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 4642 | 0.020 |
Why?
|
| Phylogeny | 1 | 2016 | 2846 | 0.020 |
Why?
|
| Microglia | 1 | 2017 | 1376 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 8635 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 2046 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2014 | 1882 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9507 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 22365 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 9425 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11138 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19041 | 0.010 |
Why?
|
| Female | 4 | 2024 | 396943 | 0.010 |
Why?
|
| Male | 4 | 2024 | 364781 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 13452 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 17647 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18388 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36497 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 42623 | 0.010 |
Why?
|
| Child | 1 | 2022 | 80863 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65409 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 223418 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 89168 | 0.000 |
Why?
|
| Adult | 1 | 2020 | 223542 | 0.000 |
Why?
|